Literature DB >> 6220592

Echocardiographic detection of right ventricular hypertrophy.

B J Baker, J A Scovil, J J Kane, M L Murphy.   

Abstract

M-mode echocardiographic right ventricular wall thickness (RVW) and diastolic right ventricular internal diameter (RVID), when above the accepted normal range (RVW less than or equal to 5 mm, RVID less than or equal to 26 mm), are frequently used clinically to predict the presence of right ventricular hypertrophy. RVID was compared to anatomic right ventricular mass (RVM) in 27 patients and to RVW in 13 patients to determine their accuracy for predicting right ventricular hypertrophy (RVM greater than 65 gm). When increased, both measurements were specific for right ventricular hypertrophy. The specificity for RVW above 5 mm was 100% and for RVID greater than 26 mm was 79%. Neither was a sensitive indicator of hypertrophy. Only 36% of those with anatomic right ventricular hypertrophy had an echocardiographically dilated ventricle, and 67% had a thickened free wall. Neither measurement proved to be an accurate predictor of RVM, with a correlation for RVW of 0.56 and for diastolic RVID of 0.19.

Entities:  

Mesh:

Year:  1983        PMID: 6220592     DOI: 10.1016/0002-8703(83)90485-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

1.  Echocardiographic measurements of the right ventricle: right ventricular outflow tract 1.

Authors:  K Loiske; S Hammar; K Emilsson
Journal:  Clin Res Cardiol       Date:  2010-03-07       Impact factor: 5.460

2.  Childhood acquired heart disease in Nigeria: an echocardiographic study from three centres.

Authors:  Sadoh E Wilson; Uzodimma C Chinyere; Daniels Queennette
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

3.  Pre-anesthetic echocardiographic findings in children undergoing non-cardiac surgery at the University of Benin Teaching Hospital, Nigeria.

Authors:  Wilson E Sadoh; Paul Ikhurionan; Charles Imarengiaye
Journal:  Cardiovasc J Afr       Date:  2016-09-09       Impact factor: 1.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.